Q-linea AB (publ) (STO:QLINEA)

Market Cap	214.39M
Revenue (ttm)	8.94M
Net Income (ttm)	-206.13M
Shares Out	4.45B
EPS (ttm)	-0.32
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,200,894
Average Volume	23,597,331
Open	0.0484
Previous Close	0.0485
Day's Range	0.0452 - 0.0484
52-Week Range	0.0304 - 5.6000
Beta	0.95
RSI	49.56
Earnings Date	Jul 10, 2025

About Q-linea AB

Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in the United Kingdom. The company offers ASTar, an antimicrobial susceptibility testing technologies used in the treatment of bloodstream infections and sepsis. It serves healthcare providers. The company was incorporated in 2007 and is headquartered in Uppsala, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2007
• Employees: 94
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: QLINEA

Financial Performance

In 2024, Q-linea AB's revenue was 5.79 million, an increase of 4.55% compared to the previous year's 5.53 million. Losses were -216.87 million, -5.45% less than in 2023.